INDV vs TMDX: fair value comparison
Indivior Pharmaceuticals, Inc. and TransMedics Group, Inc. · Updated 2026-10-19
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, INDV currently sits closer to the top of our ranking by discount to fair value. TMDX carries the stronger quality grade.
| INDV | TMDX | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $32.45 | $70.78 |
| 12-month range | $24.78–$41.83 | $62.04–$150.42 |
| Rank by discount to fair value | #17 of 108 Healthcare | #100 of 108 Healthcare |
| Quality grade | F | B |
| Leverage | Low | High |
| Margin trend | Stable | Stable |
| Revenue growth | Modest | High |
| RSI zone | Neutral | Oversold |
| 50/200-day trend | Mixed | Downtrend |
| 52-week position | The lower-middle quarter | The bottom quarter |
Full single-stock breakdowns: INDV fair value analysis · TMDX fair value analysis